Treadmill Cardiovascular Safety Study of Erenumab (AMG 334)

Clinical trial NCT02575833 · COMPLETED

Trial details

NCT number

NCT02575833

Sponsor

Amgen

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2015-11-23

Primary completion

2017-01-23

Enrollment

89

View on ClinicalTrials.gov